and BV60 (tor2-51, Pck2-HA) were grown in YES medium and treated with 1µg/ml Caspofungin, or shifted to the same medium without glucose and supplemented with 3% glycerol. Cell extracts were resolved by SDS-PAGE and Pck2 levels were detected after incubation with anti-HA antibodies. Anti-Cdc2 was used as a loading control.
(B) Strains AN0179 (Psk1-13myc; control), BV91 (tor1∆ Psk1-13myc), and BV92
(tor2-51 Psk1-13myc), were grown in YES medium, pre-incubated with or without 50
µM Torin for 60 min (control cells), or at 36ºC for one hour (tor2-51 cells), and shifted to the same medium without glucose and supplemented with 3% glycerol. The Psk1-13myc fusion was detected after incubation with anti-myc antibodies. Arrow, unphosphorylated Psk1; asterisk, TORC1-phosphorylated Psk1.
(C) A growing culture of control strain BV8 (Pck2-HA) was first incubated with 50 µM Torin for 60 min or remained untreated (DMSO). These cells, together with a culture of strain BV14 (psk1∆ gad8∆ Pck2-HA) were treated afterwards with 1 μg/ml
Caspofungin for the indicated times. Pck2 was detected as described above. *,P<0.05 in
Torin-treated cells as compared to the untreated culture. Growing cultures of strains described in (A) were grown in YES medium with 7% glucose and then shifted to the same medium without glucose and supplemented with 3% glycerol.
Cell extracts were resolved by SDS-PAGE and Pck2 levels were detected after incubation with anti-HA antibodies. Anti-Cdc2 was used as a loading control. (C) Growing cultures of strains described in (A) were treated with 0.6 M KCl. Activated Pmk1 was detected with anti-phospho-p44/42 antibody, whereas anti-Cdc2 was used as a loading control. and Y05171 (ypt6∆) were incubated at 39ºC, or treated with either 12 mM Caffeine, 10 µg/ml Calcofluor White (CFW), 1 µg/ml Caspofungin (Casp.) or 0.5 M NaCl. Activated Slt2 and Hog1 were detected with anti-phospho-p44/42 and anti-phospho-p38
antibodies, respectively, whereas anti-Cdc2 (Cdc28) was used as a loading control. 
